Luciano Vellón

Inhibition of fatty acid synthase (FAS) suppresses<i>HER2/neu</i>(<i>erb</i>B-2) oncogene overexpression in cancer cells

Javier A. Menéndez, Luciano Vellón, Inderjit Mehmi et al. · Proceedings of the National Academy of Sciences · 2004 · 318 citations · Full text

Oleic acid, the main monounsaturated fatty acid of olive oil, suppresses Her-2/neu (erbB-2) expression and synergistically enhances the growth inhibitory effects of trastuzumab (Herceptin™) in breast cancer cells with Her-2/neu oncogene amplification

Javier A. Menéndez, Luciano Vellón, Rámón Colomer et al. · Annals of Oncology · 2005 · 260 citations

Tumor Biology, Oleic Acid, Breast Oncology +13

Autophagy positively regulates the CD44⁺CD24^-/lowbreast cancer stem-like phenotype

Sílvia Cufí, Alejandro Vázquez‐Martín, Cristina Oliveras‐Ferraros et al. · Cell Cycle · 2011 · 182 citations · Full text

Antitumoral actions of the anti-obesity drug orlistat (Xenical™) in breast cancer cells: blockade of cell cycle progression, promotion of apoptotic cell death and PEA3-mediated transcriptional repression of Her2/neu (erbB-2) oncogene

Javier A. Menéndez, Luciano Vellón, Ruth Lupu · Annals of Oncology · 2005 · 177 citations

Breast Oncology, Oncology, Cell Cycle Progression +10

A novel CYR61-triggered ‘CYR61-αvβ3 integrin loop’ regulates breast cancer cell survival and chemosensitivity through activation of ERK1/ERK2 MAPK signaling pathway

Javier A. Menéndez, Luciano Vellón, Inderjit Mehmi et al. · Oncogene · 2004 · 153 citations

Signal Transduction, Signaling Pathway, Erk1/erk2 Mapk +11